About [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid
[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid (PubChem CID 87083044) has the molecular formula C61H74F4N10O8
and a molecular weight of 1151.32 g/mol. Its IUPAC name is [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid.
Frequently Asked Questions
What is the IUPAC name of [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid?
The IUPAC name of [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid (CID 87083044) is [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid.
What is the SMILES notation for [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid?
The canonical SMILES for [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid is CN(C(=O)O)[C@H](C(=O)N1[C@H](c2nc3cc(F)c([C@H]4CC[C@H](c5cc6[nH]c([C@@H]7C[C@@H]8CCC[C@@H]8N7C(=O)[C@H](C7CCOCC7)N(C)C(=O)O)nc6cc5F)N4c4cc(F)c(N5CCCCC5)c(F)c4)cc3[nH]2)C[C@@H]2CCC[C@@H]21)C1CCOCC1.
What is the InChIKey of [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid?
The InChIKey is NLYRRDNQGNMTDK-ZPZIASKSSA-N. The full InChI is InChI=1S/C61H74F4N10O8/c1-70(60(78)79)53(32-14-20-82-21-15-32)58(76)74-47-10-6-8-34(47)24-51(74)56-66-43-28-37(39(62)30-45(43)68-56)49-12-13-50(73(49)36-26-41(64)55(42(65)27-36)72-18-4-3-5-19-72)38-29-44-46(31-40(38)63)69-57(67-44)52-25-35-9-7-11-48(35)75(52)59(77)54(71(2)61(80)81)33-16-22-83-23-17-33/h26-35,47-54H,3-25H2,1-2H3,(H,66,68)(H,67,69)(H,78,79)(H,80,81)/t34-,35-,47-,48-,49+,50+,51-,52-,53-,54-/m0/s1.
What are the key properties of [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid?
[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid has a molecular weight of 1151.32 g/mol, XLogP of 10.76, 12 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-[carboxy(methyl)amino]-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylphenyl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-methylcarbamic acid is sourced from PubChem (CID 87083044), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).